PARP Inhibitors For Advanced Prostate Cancer PARP inhibitors are a newer class of oral therapies for advanced prostate cancer that target faulty DNA repair mechanisms. This class of drugs is ...

How Hormone Therapy Halts Cancer Growth Hormone therapy, also known as androgen deprivation therapy (ADT), is the foundation of treatment for advanced prostate cancer. The treatment approach works by ...

Advanced Testing Helps Doctors Pick The Best Treatment Approach For men facing advanced prostate cancer, doctors may order a series of tests to assess how far the cancer has spread and what treatment ...

Targeted Radiation For Advanced Prostate Cancer Radioligand therapy, such as Pluvicto, delivers targeted radiation to prostate cancer cells by binding to PSMA, a protein commonly found on these cells, ...

SYNOPSIS In this candid roundtable conversation, you’ll hear from a mom rebuilding her life, a devoted caregiver, a breast cancer specialist, and a leading researcher. Together, they unpack the ...

Follicular Lymphoma: A Slow-Growing Blood Cancer Follicular lymphoma is a type of non-Hodgkin lymphoma. It is a slow-growing blood cancer that is considered incurable — however, because it grows so ...

Addressing Disparities in Access to Cancer Care The effort to address the disparities in access to cancer care spans industries, so SurvivorNet sat down with Suneet Varma, Global Oncology & U.S.

Isabella Strahan's Brain Cancer Journey Since Isabella Strahan went into remission from a type of brain cancer called medulloblastoma just last year, and the 20-year-old University of Southern ...

Coping With Grief Amid MS Christina Applegate is urging fellow thrivers of Multiple Sclerosis (MS) to understand it’s imperative not to “compare” yourself to others because the disease affects ...

How Immunotherapy Provides Added Treatment Option for Bladder Cancer Patients A 51-year-old father of two discovered early signs of bladder cancer after noticing his urine had turned “rose colored”—a ...

Increasing Screening Through Patient Education Efforts to improve cancer screening through awareness campaigns are having an impact, as a study published in JAMA indicates a “58% reduction in breast ...

PIK3 Inhibitor Inavolisib Could Delay The Need For Chemo About 35 to 40% of people with a type of advanced breast cancer known as hormone-receptor positive (HR+), HER2 negative (HER2-) have something ...